Pfizer, represented by Luzzatto, requested to amend the period of Patent Term Extension granted for IL 139110, under Section 170 of the Law which authorizes the Commissioner to adjust the Patent Register. The original patent was due to lapse on… Read More ›
Appeal to Supreme Court, Should a Judge who points out the Weakness of a Case at Pretrial, Recuse Herself for Having Preconceptions?
Yehoshua Fishler is suing G.A. Ehrlich LTD (Ehrlich & Fenster) in the Tel Aviv – Jaffa District Court. He requested that Judge M Amit Anisman withdraw from the case. The case concerns allegations and counter allegations of breach of contract… Read More ›
Fischler vs. Ehrlich – Should the Judge Recuse Herself for Expressing a Negative Opinion on Plaintiff’s Likelihood of Prevailing in Pre-trial Hearing?
This is an interim ruling concerning a financial dispute between Joshua Fischler and G.A. Ehrlich (1995) ltd. In response to a preliminary assessment that the case was weak, and plaintiff (Fischler) should post a bond to cover Ehrlich’s costs, should… Read More ›
Application for patent IL 253468 to Janssen Pharmaceuticals is a divisional application of IL 206448, filed under Section 24 of the Law. The parent application is being opposed by TEVA. TEVA has asked that the Opposition against the parent application… Read More ›
This interim ruling addresses the issue of amending the Statement of Case in Opposition proceedings before the Israel Patent Office. IL 209734 to G Patel titled “A monitoring system based on etching of metals” was allowed and published for Opposition… Read More ›
The Manufacturers Association of Israel opposed an ex-partes decision to allow a patent term extension for Dexlansoprazole, and New Commissioner Ofer Alon has disallowed the extension accepted by his predecessor. Background Dexlansoprazole is used for treating gastro-reflux and for treating… Read More ›
Israel Patent Application No. 176831 to Novartis is titled “COMPRESSED PHARMACEUTICAL TABLETS OR DIRECT COMPRESSION PHARMACEUTICAL TABLETS COMPRISING DPP-IV INHIBITOR CONTAINING PARTICLES AND PROCESSES FOR THEIR PREPARATION”. It is the national phase entry of PCT/EP2005/000400. On allowance, Unipharm filed an… Read More ›
This is the second part of a ruling concerning Patent Term Extensions (PTEs) for Kovaltry. The first part related to when the ninety day period from registration commences and is discussed here. This second part of the ruling is a precedential… Read More ›
Extension for IL 124123 to Bayer. When does the ninety day period for requesting a patent term extension commence? In this ruling, the Commissioner accepts that the 90 day period for requesting a patent term extension should be calculated from… Read More ›
IL 206845 to BioMarin Pharmaceuticals Inc. was refused under Section 21a of the Israel Patent Law 1967. The patent application was the national phase of a PCT application submitted on 6 January 2009. The national phase entry was submitted on 6 July… Read More ›